Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
VIC DRUG ALERT JUNE 2022
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Life | Free Full-Text | Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Use of Ketamine in Hospitalized Patients - The Hospitalist
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Molecules | Free Full-Text | The Ketamine Antidepressant Story: New Insights
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders